Polypid Ltd (PYPD) Straddle

Trading a PYPD straddle lets you take a pure volatility position on Polypid Ltd without committing to a direction. Polypid Ltd's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate PYPD straddle pricing in real time and find the moments when expected moves are mispriced.

A long straddle on PYPD profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Polypid Ltd stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the PYPD straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Earnings, product cycles, macro prints — any time volatility itself is the trade, the PYPD straddle is the cleanest expression of that view. Our scanner prices every PYPD straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a PYPD straddle into a catalyst or short a PYPD straddle to harvest decay, the options straddle setups that matter are all in one place.